RET and neoplasm: Abnormal activation of RET (via mechanisms such as gene rearrangements or point mutations) can activate key downstream signaling pathways such as the RAS/MAPK and PI3K/AKT pathways, driving tumor cell proliferation, survival, invasion, angiogenesis, and metastasis (12).